Taiwan-listed stock · 6919
Caliway Biopharmaceuticals (6919): insider filings
In the last 12 months, company insiders filed 12 open-market buys and 12 sales.
- Insider buys / sales
- 12 / 1212 months
- Insiders reporting
- 712 months
- Last close
- NT$77.212 Oct 2026
- One-year change
- −49.5%
24 disclosed buys and sales on record since 15 October 2025. Directors, managers and holders of more than 10% report each month’s changes by the 15th of the next. Counts are shares bought and sold on the exchange, valued at the month-end close; stock dividends, gifts, inheritance, family transfers and declared plans are left out.
Latest disclosures
| Disclosed | Filed by | Type | Amount | Traded |
|---|---|---|---|---|
| 徐坴暉Company insider (Taiwan) | Sale | ≈ $6.4K | ||
| 徐坴暉Company insider (Taiwan) | Buy | ≈ $25.1K | ||
| 林慶波Company insider (Taiwan) | Buy | ≈ $6.6K | ||
| 許安宜Company insider (Taiwan) | Sale | ≈ $97.3K | ||
| 蘇介福Company insider (Taiwan) | Sale | ≈ $78.4K | ||
| 林冠誌Company insider (Taiwan) | Sale | ≈ $367K | ||
| 林慶波Company insider (Taiwan) | Buy | ≈ $13.5K | ||
| 邱全成Company insider (Taiwan) | Buy | ≈ $189K |